225 related articles for article (PubMed ID: 11148074)
21. Expression of neurofibromatosis 2 transcript and gene product during mouse fetal development.
Huynh DP; Tran TM; Nechiporuk T; Pulst SM
Cell Growth Differ; 1996 Nov; 7(11):1551-61. PubMed ID: 8930405
[TBL] [Abstract][Full Text] [Related]
22. The merlin interacting proteins reveal multiple targets for NF2 therapy.
Scoles DR
Biochim Biophys Acta; 2008 Jan; 1785(1):32-54. PubMed ID: 17980164
[TBL] [Abstract][Full Text] [Related]
23. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
[TBL] [Abstract][Full Text] [Related]
24. The merlin tumor suppressor localizes preferentially in membrane ruffles.
Gonzalez-Agosti C; Xu L; Pinney D; Beauchamp R; Hobbs W; Gusella J; Ramesh V
Oncogene; 1996 Sep; 13(6):1239-47. PubMed ID: 8808698
[TBL] [Abstract][Full Text] [Related]
25. Evidence for a cytoskeleton attachment domain at the N-terminus of the NF2 protein.
den Bakker MA; Riegman PH; Suurmeijer AP; Vissers CJ; Sainio M; Carpen O; Zwarthoff EC
J Neurosci Res; 2000 Dec; 62(6):764-71. PubMed ID: 11107160
[TBL] [Abstract][Full Text] [Related]
26. The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association.
James MF; Manchanda N; Gonzalez-Agosti C; Hartwig JH; Ramesh V
Biochem J; 2001 Jun; 356(Pt 2):377-86. PubMed ID: 11368764
[TBL] [Abstract][Full Text] [Related]
27. Magic but treatable? Tumours due to loss of merlin.
Hanemann CO
Brain; 2008 Mar; 131(Pt 3):606-15. PubMed ID: 17940085
[TBL] [Abstract][Full Text] [Related]
28. Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations.
Gutmann DH; Haipek CA; Hoang Lu K
J Neurosci Res; 1999 Dec; 58(5):706-16. PubMed ID: 10561699
[TBL] [Abstract][Full Text] [Related]
29. The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton.
Muranen T; Grönholm M; Lampin A; Lallemand D; Zhao F; Giovannini M; Carpén O
Hum Mol Genet; 2007 Jul; 16(14):1742-51. PubMed ID: 17566081
[TBL] [Abstract][Full Text] [Related]
30. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.
Shimizu T; Seto A; Maita N; Hamada K; Tsukita S; Tsukita S; Hakoshima T
J Biol Chem; 2002 Mar; 277(12):10332-6. PubMed ID: 11756419
[TBL] [Abstract][Full Text] [Related]
32. Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate.
Sun CX; Haipek C; Scoles DR; Pulst SM; Giovannini M; Komada M; Gutmann DH
Hum Mol Genet; 2002 Dec; 11(25):3167-78. PubMed ID: 12444101
[TBL] [Abstract][Full Text] [Related]
33. Neurofibromatosis 2: loss of merlin's protective spell.
Gusella JF; Ramesh V; MacCollin M; Jacoby LB
Curr Opin Genet Dev; 1996 Feb; 6(1):87-92. PubMed ID: 8791482
[TBL] [Abstract][Full Text] [Related]
34. Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin.
McClatchey AI; Giovannini M
Genes Dev; 2005 Oct; 19(19):2265-77. PubMed ID: 16204178
[TBL] [Abstract][Full Text] [Related]
35. Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton.
den Bakker MA; Tascilar M; Riegman PH; Hekman AC; Boersma W; Janssen PJ; de Jong TA; Hendriks W; van der Kwast TH; Zwarthoff EC
Am J Pathol; 1995 Nov; 147(5):1339-49. PubMed ID: 7485397
[TBL] [Abstract][Full Text] [Related]
36. Universal absence of merlin, but not other ERM family members, in schwannomas.
Stemmer-Rachamimov AO; Xu L; Gonzalez-Agosti C; Burwick JA; Pinney D; Beauchamp R; Jacoby LB; Gusella JF; Ramesh V; Louis DN
Am J Pathol; 1997 Dec; 151(6):1649-54. PubMed ID: 9403715
[TBL] [Abstract][Full Text] [Related]
37. Schwannomin: new insights into this member of the band 4.1 superfamily.
Belliveau MJ; Lutchman M; Claudio JO; Marineau C; Rouleau GA
Biochem Cell Biol; 1995; 73(9-10):733-7. PubMed ID: 8714694
[TBL] [Abstract][Full Text] [Related]
38. Shedding light on Merlin's wizardry.
Okada T; You L; Giancotti FG
Trends Cell Biol; 2007 May; 17(5):222-9. PubMed ID: 17442573
[TBL] [Abstract][Full Text] [Related]
39. Immunoblotting analysis of schwannomin/merlin in human schwannomas.
Harwalkar JA; Lee JH; Hughes G; Kinney SE; Golubić M
Am J Otol; 1998 Sep; 19(5):654-9. PubMed ID: 9752976
[TBL] [Abstract][Full Text] [Related]
40. Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixin.
Bono P; Cordero E; Johnson K; Borowsky M; Ramesh V; Jacks T; Hynes RO
Exp Cell Res; 2005 Aug; 308(1):177-87. PubMed ID: 15913605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
